Synmosa Biopharma Corporation (TPEX: 4114)
Taiwan
· Delayed Price · Currency is TWD 37.95
+0.30 (0.80%)
Sep 10, 2024, 1:30 PM CST
Synmosa Biopharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 1,232 | 918.56 | 1,088 | 868.17 | 638.35 | 465.1 | Upgrade
|
| Short-Term Investments | 255 | 520 | 310 | 115 | 100 | 105 | Upgrade
|
| Trading Asset Securities | 343.91 | 211.45 | 20.1 | 5.26 | 7.01 | - | Upgrade
|
| Cash & Short-Term Investments | 1,831 | 1,650 | 1,418 | 988.43 | 745.35 | 570.1 | Upgrade
|
| Cash Growth | -26.31% | 16.38% | 43.43% | 32.61% | 30.74% | 27.52% | Upgrade
|
| Accounts Receivable | 1,176 | 1,155 | 1,125 | 799.64 | 702.53 | 673.81 | Upgrade
|
| Other Receivables | 61.66 | 11.46 | 20.86 | 10.47 | 16.31 | 27.46 | Upgrade
|
| Receivables | 1,237 | 1,166 | 1,146 | 810.11 | 718.84 | 701.27 | Upgrade
|
| Inventory | 1,686 | 1,651 | 1,384 | 1,214 | 1,239 | 948.74 | Upgrade
|
| Prepaid Expenses | 41.56 | - | - | 51.11 | 47.23 | 42.04 | Upgrade
|
| Other Current Assets | 14.12 | 72.07 | 60.84 | 35.05 | 231.46 | 49.69 | Upgrade
|
| Total Current Assets | 4,810 | 4,539 | 4,008 | 3,099 | 2,982 | 2,312 | Upgrade
|
| Property, Plant & Equipment | 5,528 | 5,557 | 5,638 | 5,662 | 5,788 | 4,898 | Upgrade
|
| Long-Term Investments | 305.17 | 222.87 | 223.01 | 303.48 | 271.52 | 588.3 | Upgrade
|
| Goodwill | 62.29 | 62.29 | 71.08 | 7.27 | 13.27 | 20.81 | Upgrade
|
| Other Intangible Assets | 461.67 | 496.56 | 496.8 | 494.03 | 536.69 | 559.9 | Upgrade
|
| Long-Term Deferred Tax Assets | 344.85 | 330.56 | 331.78 | 329.28 | 311.7 | 242.55 | Upgrade
|
| Other Long-Term Assets | 558.39 | 519.9 | 433.53 | 421.53 | 473.71 | 108.15 | Upgrade
|
| Total Assets | 12,070 | 11,729 | 11,203 | 10,317 | 10,377 | 8,730 | Upgrade
|
| Accounts Payable | 394.88 | 427.54 | 446.16 | 249.58 | 184.26 | 306.39 | Upgrade
|
| Accrued Expenses | 304.12 | 381.68 | 368.47 | 264.64 | 260.62 | 207.91 | Upgrade
|
| Short-Term Debt | 765.68 | 661.22 | 584.08 | 763.77 | 630.76 | 1,192 | Upgrade
|
| Current Portion of Long-Term Debt | 77.63 | 289.39 | 584.42 | 413.9 | 256.53 | 356.95 | Upgrade
|
| Current Portion of Leases | 22.97 | 23.3 | 16.7 | 6.74 | 6.83 | 7.51 | Upgrade
|
| Current Income Taxes Payable | 112.8 | 118.29 | 95.54 | 53.18 | 54.61 | 2.75 | Upgrade
|
| Current Unearned Revenue | 156.01 | 172.29 | 173.43 | 126.87 | 129.31 | 100.12 | Upgrade
|
| Other Current Liabilities | 330.44 | 44.71 | 53.91 | 10.21 | 36.74 | 25.38 | Upgrade
|
| Total Current Liabilities | 2,165 | 2,118 | 2,323 | 1,889 | 1,560 | 2,199 | Upgrade
|
| Long-Term Debt | 1,587 | 1,400 | 2,122 | 2,272 | 2,804 | 1,656 | Upgrade
|
| Long-Term Leases | 51.32 | 58.66 | 48.42 | 6.76 | 3.84 | 8.15 | Upgrade
|
| Long-Term Unearned Revenue | 2.35 | 2.35 | - | - | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 35.43 | 35.45 | 34.52 | 34.2 | 35.11 | 20.27 | Upgrade
|
| Other Long-Term Liabilities | 0.43 | 0.53 | 12.62 | 0.89 | 0.86 | 1.2 | Upgrade
|
| Total Liabilities | 3,852 | 3,628 | 4,554 | 4,221 | 4,423 | 3,917 | Upgrade
|
| Common Stock | 3,959 | 4,014 | 3,437 | 3,131 | 2,808 | 2,442 | Upgrade
|
| Additional Paid-In Capital | 2,100 | 2,195 | 1,425 | 1,426 | 1,403 | 1,336 | Upgrade
|
| Retained Earnings | 860.1 | 1,092 | 1,005 | 613.43 | 713.49 | 113.9 | Upgrade
|
| Treasury Stock | -334.98 | -486.96 | -486.96 | -402.62 | -350.87 | -356.81 | Upgrade
|
| Comprensive Income & Other | 333.34 | -104.78 | -68.18 | -63.04 | -73.45 | -50.76 | Upgrade
|
| Total Common Equity | 6,917 | 6,710 | 5,312 | 4,706 | 4,500 | 3,484 | Upgrade
|
| Minority Interest | 1,300 | 1,391 | 1,337 | 1,390 | 1,455 | 1,329 | Upgrade
|
| Shareholders' Equity | 8,218 | 8,101 | 6,649 | 6,095 | 5,955 | 4,813 | Upgrade
|
| Total Liabilities & Equity | 12,070 | 11,729 | 11,203 | 10,317 | 10,377 | 8,730 | Upgrade
|
| Total Debt | 2,505 | 2,433 | 3,355 | 3,463 | 3,702 | 3,221 | Upgrade
|
| Net Cash (Debt) | -673.58 | -782.59 | -1,937 | -2,474 | -2,956 | -2,651 | Upgrade
|
| Net Cash Per Share | -1.60 | -1.92 | -4.94 | -6.26 | -7.65 | -7.53 | Upgrade
|
| Filing Date Shares Outstanding | 420.25 | 420.25 | 390.19 | 393.6 | 396.58 | 367.72 | Upgrade
|
| Total Common Shares Outstanding | 420.25 | 420.25 | 390.19 | 393.6 | 396.58 | 367.72 | Upgrade
|
| Working Capital | 2,645 | 2,421 | 1,686 | 1,210 | 1,423 | 113.06 | Upgrade
|
| Book Value Per Share | 16.46 | 15.97 | 13.61 | 11.95 | 11.35 | 9.47 | Upgrade
|
| Tangible Book Value | 6,394 | 6,151 | 4,744 | 4,204 | 3,950 | 2,903 | Upgrade
|
| Tangible Book Value Per Share | 15.21 | 14.64 | 12.16 | 10.68 | 9.96 | 7.89 | Upgrade
|
| Land | 3,528 | 3,528 | 3,558 | 3,558 | 3,567 | 2,813 | Upgrade
|
| Buildings | 1,569 | 1,567 | 1,558 | 1,542 | 1,561 | 1,411 | Upgrade
|
| Machinery | 1,956 | 1,893 | 1,790 | 1,696 | 1,728 | 1,583 | Upgrade
|
| Construction In Progress | 34.06 | 19.08 | 9.74 | 62.51 | 47.32 | 21.96 | Upgrade
|
| Leasehold Improvements | 83.53 | 80.49 | 78.96 | 22.62 | 19.93 | 20.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.